Independent report

Review and update of the prescription for Prescribed Disease D1 (Pneumoconiosis)

The Industrial Injuries Advisory Council (IIAC) has reviewed the prescription for the Prescribed Disease (PD) pneumoconiosis.

• From: Industrial Injuries Advisory Council
• Published: 16 November 2023

Documents

Review and update of the prescription for Prescribed Disease D1 (Pneumoconiosis)

Ref: ISBN 978-1-5286-4532-4, CP 964

PDF, 9.21 MB, 37 pages

Order a copy

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Review and Update of the Prescription for Prescribed Disease D1 (Pneumoconiosis)

Ref: ISBN 978-1-5286-4532-4, E03011705 11/23 , CP 964

HTML

Order a copy

Details

The Industrial Injuries Advisory Council (IIAC) has reviewed the prescription for pneumoconiosis, including silicosis and asbestosis, (PD D1), which is covered by industrial injuries disablement benefit. The current prescription for PD D1 dates back in part over 100 years and has not undergone any major revision for almost 80 years. In that time the causes of the disease and the diagnostic techniques have changed substantially. IIAC anticipates the revised prescription will mean the prescription will be easier to navigate for both claimants and administrators.

Published 16 November 2023